Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9(®) lead to promotion versus suppression of prostate cancer metastasis

Guardado en:
Detalles Bibliográficos
Publicado en:J Biol Chem
Autores principales: Lin, Tzu-Hua, Lee, Soo Ok, Niu, Yuanjie, Xu, Defeng, Liang, Liang, Li, Lei, Yeh, Shauh-Der, Fujimoto, Naohiro, Yeh, Shuyuan, Chang, Chawnshang
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Biochemistry and Molecular Biology 2020
Materias:
Additions and Corrections
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7667975/
https://ncbi.nlm.nih.gov/pubmed/33188084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.AAC120.016502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares